ProfileGDS4177 / 229846_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 77% 80% 82% 82% 74% 75% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated164.7377
GSM603099KU-812 non-treated212.1180
GSM603098KCL-22 Imatinib-treated264.0182
GSM603097KCL-22 non-treated255.0682
GSM603102JURL-MK1 Imatinib-treated129.5674
GSM603101JURL-MK1 non-treated144.0475